GO:0006742 NADP+ catabolic process: Genes & Methods

NADP+ catabolic process (GO:0006742) is the set of chemical reactions and pathways that result in the breakdown of nicotinamide adenine dinucleotide phosphate (NADP+), a coenzyme that interconverts with its reduced form NADPH in many redox and biosynthetic reactions. This process is fundamental to cellular redox homeostasis because NADP+ and NADPH serve as essential electron carriers in anabolic metabolism, antioxidant systems, and mitochondrial energy transduction [1,2]. Researchers study GO:0006742 to understand how cells regulate the availability of NADP+ for dehydrogenases and how catabolic flux influences biosynthetic capacity and stress responses [2,7]. The NADP+/NADPH couple is distinct from the NAD+/NADH couple, although both are pyridine dinucleotides with overlapping roles in energy metabolism and signaling [1,7]. NADPH provides reducing power for fatty acid synthesis, cholesterol synthesis, nucleotide biosynthesis, and regeneration of reduced glutathione, while NADP+ is the electron acceptor for enzymes such as glucose-6-phosphate dehydrogenase and malic enzyme [1,2]. Consequently, the catabolic process that degrades or interconverts NADP+ is tightly linked to metabolic state, oxidative stress, and cell fate decisions [2,8]. Dysregulation of NADP+ catabolic process has been implicated in cancer metabolism, neurodegeneration, and metabolic disorders, making it a compelling target for functional genomics and therapeutic development [7,8]. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0006742, its molecular players, and the CRISPR-based methods used to interrogate it [1,2,7,8].

In our own words, GO:0006742 (NADP+ catabolic process) encompasses the biochemical reactions and pathways that break down nicotinamide adenine dinucleotide phosphate (NADP+), the oxidized form of a coenzyme that reversibly converts to NADPH during redox and biosynthetic reactions. The term includes catabolic steps that reduce the cellular pool of NADP+ or its reduced counterpart NADPH, thereby influencing the availability of reducing equivalents for anabolic processes and antioxidant defense [1,2].

NADP+ catabolic process is important because it controls the cellular balance between NADP+ and NADPH, which directly affects reductive biosynthesis, antioxidant capacity, and mitochondrial metabolism [1,2]. Because NADPH is required for glutathione regeneration and lipid synthesis, changes in NADP+ catabolism can alter susceptibility to oxidative stress and influence cell proliferation or death [2,7]. In addition, mitochondrial NADP(H) integrates redox and metabolic signals, linking this process to cancer, neurodegeneration, and metabolic disease.

The following genes and proteins are central to NADP+ catabolic process and its regulation, based on verified literature [1,2,7,8].

NADP+ catabolic process is regulated at multiple levels, including transcriptional control of NADP(H)-metabolizing enzymes, post-translational modification of dehydrogenases, and feedback from redox-sensitive signaling pathways [1,2]. Mitochondrial NADP(H) metabolism is integrated with energy status and stress signals, allowing cells to adjust catabolic flux in response to metabolic demand. In addition, the pentose phosphate pathway and malic enzyme flux modulate NADPH availability, indirectly influencing NADP+ catabolism [1,7].

Altered NADP(H) metabolism supports cancer cell proliferation by providing reducing power for biosynthesis and antioxidant defense. Mutations in IDH1 and IDH2 disrupt NADPH production and contribute to oncogenesis, highlighting the importance of NADP+ catabolic process in cancer.

Oxidative stress and impaired NADPH regeneration are implicated in neurodegenerative diseases, where NADP+ catabolic process dysregulation can exacerbate neuronal damage [2,7].

Mitochondrial NADP(H) integrates redox and metabolic signals, and its dysfunction is linked to metabolic disorders such as insulin resistance and obesity.

RNA-seq and CRISPR screening can identify genes that regulate NADP+ catabolic process and its downstream effects on redox homeostasis [1,8].

Mass spectrometry-based metabolomics quantifies NADP+, NADPH, and related metabolites to measure catabolic flux [1,7].

Genetically encoded NADP(H) biosensors enable real-time monitoring of redox changes in live cells.

Proteomics can reveal how NADP+ catabolic process enzymes are modified and interact with signaling networks [2,7].

Researchers studying NADP+ catabolic process-related genes often need to determine whether a candidate gene is causally involved in redox regulation, metabolic flux, or disease phenotypes. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such functional studies.

NADP+ catabolic process (GO:0006742) is a central component of cellular redox biology, controlling the balance between NADP+ and NADPH and influencing biosynthesis, antioxidant defense, and cell fate [1,2]. Dysregulation of this process is linked to cancer, neurodegeneration, and metabolic disorders, making it a key area for functional genomics [7,8]. CRISPR-based models provide powerful tools to dissect the causal roles of NADP(H)-related genes and to identify new therapeutic targets [1,8].